ArticleCureus2026
Significance of Pleural Fluid Neutrophil-Lymphocyte Ratio and Pleural Fluid Protein as Additional Biomarkers in Differentiating Tubercular Pleural Effusions From Non-tubercular Effusions.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTubercular pleural effusion (TPE) remains a significant diagnostic challenge in tuberculosis-endemic regions. Current diagnostic methods have substantial limitations, necessitating the investigation of complementary biomarkers.
objectivesThe primary objective of this study was to evaluate the diagnostic utility of pleural fluid neutrophil-lymphocyte ratio (NLR) and pleural fluid protein as adjunctive biomarkers, in combination with adenosine deaminase (ADA), for differentiating TPEs from non-tubercular effusions (NTEs). The secondary objective was to assess their potential clinical utility as simple, cost-effective adjuncts in routine diagnostic practice.
methodsA case-control study involving 50 patients (25 TPE cases, 25 NTE controls) was conducted at Vinayaka Missions Medical College and Hospital over 18 months. Pleural fluid was analyzed for protein concentration, cell counts (for NLR calculation), ADA levels, and
resultsMean pleural fluid NLR was significantly elevated in TPE (1.63 ± 6.37) versus NTE controls (0.77 ± 2.06; p = 0.047). Pleural fluid protein showed marked elevation in TPE patients (4.67 ± 2.36 g/dL) versus controls (2.90 ± 1.85 g/dL; p = 0.014). Pleural ADA demonstrated superior discrimination (TPE: 84.95 ± 21.10 U/L versus NTE: 21.45 ± 15.78 U/L; p < 0.0001). Combined analysis of elevated pleural protein, elevated NLR, and elevated ADA provided enhanced diagnostic accuracy: sensitivity: 96%, specificity: 92%, positive predictive value: 95%, and negative predictive value: 94%.
conclusionPleural fluid protein and NLR serve as useful adjunctive biomarkers in the diagnostic evaluation of pleural effusions. When combined with ADA, these readily available, cost-effective parameters substantially enhance diagnostic accuracy for differentiating TPEs from NTEs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.